- Marcus Corp (NYSE:MCS) reported second-quarter FY21 sales growth of 1066% year-on-year, to $92.55 million, beating the analyst consensus of $83.53 million.
- Operating loss narrowed 50.8% Y/Y to $(26.1) million.
- Total costs and expenses soared 94.5% Y/Y to $118.7 million.
- The company held $15.1 million in cash and equivalents as of July 1, 2021.
- Adjusted loss per share was $(0.67), versus the consensus for a loss of $(0.76).
- “While it will take some time to return to pre-pandemic levels, we are encouraged by the positive momentum in both our operating businesses which contributed to positive company-wide adjusted EBITDA for the month of June,” said CEO Gregory S. Marcus.
- Price action: MCS shares are trading lower by 2.75% at $15.21 on the last check Wednesday.
InMed Reports FY22 Net Loss Of $33.17/Share Compared To A Net Loss Of $37.96/Share YoY
For the year ended June 30, 2022, the Company recorded a net loss of $18.6 million, or $33.17 per share, compared with a net loss of $10.2 million or $37.96 per share, for the previous
